← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2015Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2015
Akros— Founded
Drugs by trial phase (22 distinct, 26 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Familial Primary Pulmonary Hypertension
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperlipoproteinemia Type II
- Hypertension
- Kidney Diseases
- Kidney Failure, Chronic
- Malaria
- Psoriasis
- Renal Insufficiency, Chronic
- Skin Diseases
- Virus Diseases
Recent trials (36)
- NCT07247266Lead sponsorPhase 1Dec 31, 2025
- NCT06017609Lead sponsorPhase 2Aug 11, 2023
- NCT04465877Lead sponsorPhase 1Jun 15, 2020
- NCT03789643Lead sponsorPhase 2Mar 31, 2019
- NCT03832738Lead sponsorPhase 2Jan 17, 2019
- NCT03358290Lead sponsorPhase 2Nov 10, 2017
- NCT03018509Lead sponsorPhase 1Dec 1, 2016
- NCT02919475Study chairPhase 2Sep 1, 2016
- NCT02919475Lead sponsorPhase 2Sep 1, 2016
- NCT02805244Lead sponsorPhase 1Jun 1, 2016
- NCT02654912Overall official - principal investigatorPhase 4Feb 1, 2016
- NCT02654912CollaboratorPhase 4Feb 1, 2016
- NCT02581124Lead sponsorPhase 1Oct 1, 2015
- NCT02120976Study chairPhase 1Apr 1, 2014
- NCT02120976Lead sponsorPhase 1Apr 1, 2014
Details
- Founded
- Durham, NC, US Jun 1, 2015
- Last known activity
- Dec 31, 2025